MATAURO’s AMN Healthcare AMN Stock Holding History

MATAURO’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-58,619	Closed	-$1.13M	–	153
2025 Q3	$1.13M	Buy	+58,619	New	+$1.14M	0.18%	71

Other funds holding AMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MATAURO's AMN Position: Q4 2025 in Review

MATAURO sold out of AMN Healthcare (AMN) in Q4 2025, closing a stake of 58,619 shares — an estimated $1.13M sold.

MATAURO first reported a position in AMN in Q3 2025 and held it in 1 quarter. The position peaked at $1.13M in Q3 2025. 236 funds tracked by Wall St. Rank hold AMN as of Q4 2025.

MATAURO reported no remaining AMN Healthcare position as of Q4 2025 after selling out during the quarter.
MATAURO sold 58,619 AMN Healthcare shares in Q4 2025, an estimated $1.13M.
MATAURO first reported a position in AMN Healthcare in Q3 2025 and held it in 1 quarter.
MATAURO's AMN Healthcare position peaked at $1.13M in Q3 2025.
236 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2025.

Based on MATAURO's 13F filing for Q4 2025, filed 16 Jan 2026.